Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.

Gill KE, Pierre PJ, Daunais J, Bennett AJ, Martelle S, Gage HD, Swanson JM, Nader MA, Porrino LJ.

Neuropsychopharmacology. 2012 Nov;37(12):2555-65. doi: 10.1038/npp.2012.117. Epub 2012 Jul 18.

2.

Effects of chronic methylphenidate in adolescence on later methylphenidate self-administration in rhesus monkeys.

Martelle SE, Porrino LJ, Nader MA.

Behav Pharmacol. 2013 Sep;24(5-6):478-81. doi: 10.1097/FBP.0b013e328364bfee.

3.

Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations.

Calipari ES, Ferris MJ, Melchior JR, Bermejo K, Salahpour A, Roberts DC, Jones SR.

Addict Biol. 2014 Mar;19(2):145-55. doi: 10.1111/j.1369-1600.2012.00456.x. Epub 2012 Mar 28.

4.

Long-term exposure to oral methylphenidate or dl-amphetamine mixture in peri-adolescent rhesus monkeys: effects on physiology, behavior, and dopamine system development.

Soto PL, Wilcox KM, Zhou Y, Kumar A, Ator NA, Riddle MA, Wong DF, Weed MR.

Neuropsychopharmacology. 2012 Nov;37(12):2566-79. doi: 10.1038/npp.2012.119. Epub 2012 Jul 18. Erratum in: Neuropsychopharmacology. 2013 May;38(6):1141. Kumar, Anil [added].

5.

Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents.

Thanos PK, Michaelides M, Benveniste H, Wang GJ, Volkow ND.

Pharmacol Biochem Behav. 2007 Oct;87(4):426-33. Epub 2007 Jun 5.

PMID:
17599397
6.

Effects of chronic methylphenidate on cocaine self-administration under a progressive-ratio schedule of reinforcement in rhesus monkeys.

Czoty PW, Martelle SE, Gould RW, Nader MA.

J Pharmacol Exp Ther. 2013 Jun;345(3):374-82. doi: 10.1124/jpet.113.204321. Epub 2013 Apr 11.

7.

Social dominance in female monkeys: dopamine receptor function and cocaine reinforcement.

Nader MA, Nader SH, Czoty PW, Riddick NV, Gage HD, Gould RW, Blaylock BL, Kaplan JR, Garg PK, Davies HM, Morton D, Garg S, Reboussin BA.

Biol Psychiatry. 2012 Sep 1;72(5):414-21. doi: 10.1016/j.biopsych.2012.03.002. Epub 2012 Apr 14.

8.

Abstinence from chronic cocaine self-administration alters striatal dopamine systems in rhesus monkeys.

Beveridge TJ, Smith HR, Nader MA, Porrino LJ.

Neuropsychopharmacology. 2009 Apr;34(5):1162-71. doi: 10.1038/npp.2008.135. Epub 2008 Sep 3.

9.

Dopamine D2/D3 receptors modulate cocaine's reinforcing and discriminative stimulus effects in rhesus monkeys.

Sinnott RS, Mach RH, Nader MA.

Drug Alcohol Depend. 1999 Apr 1;54(2):97-110.

PMID:
10217549
10.
11.

Long-term safety of stimulant use for ADHD: findings from nonhuman primates.

Volkow ND.

Neuropsychopharmacology. 2012 Nov;37(12):2551-2. doi: 10.1038/npp.2012.127. No abstract available.

12.

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, Biederman J, Kollins S, Nguyen AS, DeCory HH, Hirshe Dirksen SJ, Hatch SJ; COMACS Study Group.

Pediatrics. 2004 Mar;113(3 Pt 1):e206-16.

PMID:
14993578
13.

The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics.

Lile JA, Wang Z, Woolverton WL, France JE, Gregg TC, Davies HM, Nader MA.

J Pharmacol Exp Ther. 2003 Oct;307(1):356-66. Epub 2003 Sep 3.

14.

Methylphenidate as a reinforcer for rats: contingent delivery and intake escalation.

Marusich JA, Beckmann JS, Gipson CD, Bardo MT.

Exp Clin Psychopharmacol. 2010 Jun;18(3):257-66. doi: 10.1037/a0019814.

15.

Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.

Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, Howell LL.

J Pharmacol Exp Ther. 2004 Jun;309(3):959-69. Epub 2004 Feb 24.

16.

Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.

Hiranita T, Soto PL, Kohut SJ, Kopajtic T, Cao J, Newman AH, Tanda G, Katz JL.

J Pharmacol Exp Ther. 2011 Nov;339(2):662-77. doi: 10.1124/jpet.111.185025. Epub 2011 Aug 22.

17.

Impact of early life stress on the reinforcing and behavioral-stimulant effects of psychostimulants in rhesus monkeys.

Ewing Corcoran SB, Howell LL.

Behav Pharmacol. 2010 Feb;21(1):69-76. doi: 10.1097/FBP.0b013e3283359f53.

18.

Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.

Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G, Schoevers RA, Booij J.

Eur Neuropsychopharmacol. 2013 Dec;23(12):1714-23. doi: 10.1016/j.euroneuro.2013.05.002. Epub 2013 May 31.

PMID:
23731497
19.

Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate.

Calipari ES, Ferris MJ, Siciliano CA, Jones SR.

ACS Chem Neurosci. 2015 Jan 21;6(1):155-62. doi: 10.1021/cn500262x. Epub 2014 Dec 18.

20.

Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.

Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, Howell LL.

Synapse. 2002 Jan;43(1):78-85.

PMID:
11746736

Supplemental Content

Support Center